<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03176537</url>
  </required_header>
  <id_info>
    <org_study_id>1.906.729</org_study_id>
    <nct_id>NCT03176537</nct_id>
  </id_info>
  <brief_title>Periodontal Profile of Hypogonadic Men</brief_title>
  <official_title>Clinical, Microbiologic and Immunologic Profile of the Periodontal Condition in Hypogonadic Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Paraná</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidade Estadual Paulista - UNESP</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universidade de Guarulhos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal do Paraná</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess if hypogonadic men with periodontitis benefit from
      testosterone replacement therapy before being submitted to periodontal treatment. Fifty
      hypogonadic men (Total Testosterone &lt;200ng/dL) will be recruited from the Clinics Hospital at
      Federal University of Paraná and subjected to periodontal evaluation by a trained and
      calibrated researcher. The subjects presenting with periodontitis (assessed by clinical
      parameters) will be randomly allocated to &quot;testosterone replacement therapy&quot; (TRT) group or
      &quot;placebo&quot; for 3 months. After that time, all patients will receive nonsurgical periodontal
      treatment, which will be reassessed after 45 days. Clinical parameters (such as probing
      depth, gingival and plaque index, clinical attachment loss, bleeding on probing), sub
      gingival plaque and gingival crevicular fluid will be collected at baseline, just before
      therapy and 45 days after therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>&quot;Placebo&quot; and &quot;TRT&quot; groups</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Placebo</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>CAL</measure>
    <time_frame>4.5 months</time_frame>
    <description>Clinical Attachment Loss</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PPD</measure>
    <time_frame>4.5months</time_frame>
    <description>probing pocket depth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PPD</measure>
    <time_frame>3months</time_frame>
    <description>probing pocket depth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BOP</measure>
    <time_frame>3months</time_frame>
    <description>bleeding on probing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BOP</measure>
    <time_frame>4.5months</time_frame>
    <description>bleeding on probing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Micro-organisms concentration</measure>
    <time_frame>4.5months</time_frame>
    <description>DNA hybridization - checkerboard</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Micro-organisms concentration</measure>
    <time_frame>3months</time_frame>
    <description>DNA hybridization - checkerboard</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of inflammatory markers in crevicular fluid</measure>
    <time_frame>3months</time_frame>
    <description>Multiplex assay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of inflammatory markers in crevicular fluid</measure>
    <time_frame>4.5 months</time_frame>
    <description>Multiplex assay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Periodontitis</condition>
  <condition>Hypogonadism, Male</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Gel, daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testosterone Replacement Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Testosterone gel</intervention_name>
    <description>Androgel (50mg testosterone), gel, daily</description>
    <arm_group_label>TRT</arm_group_label>
    <other_name>TRT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>Placebo, gel, daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: total testosterone &lt;200ng/dL in two assessments; at least 20 teeth
        present.

        Exclusion Criteria: systemic diseases such as hormonal, inflammatory and immune
        alterations.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joao P Steffens, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UFPR</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephanie C Warnavin, DDS</last_name>
    <phone>+5547999158292</phone>
    <email>testosterona.ufpr@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clínica de Odontologia da Universidade Federal do Paraná</name>
      <address>
        <city>Curitiba</city>
        <state>PR</state>
        <zip>80210170</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joao P Steffens, PhD</last_name>
      <phone>+554133604032</phone>
      <email>joao.steffens@ufpr.br</email>
    </contact>
    <investigator>
      <last_name>Stephanie C Warnavin, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joao P Steffens, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Steffens JP, Coimbra LS, Rossa C Jr, Kantarci A, Van Dyke TE, Spolidorio LC. Androgen receptors and experimental bone loss - an in vivo and in vitro study. Bone. 2015 Dec;81:683-690. doi: 10.1016/j.bone.2015.10.001. Epub 2015 Oct 9.</citation>
    <PMID>26450018</PMID>
  </reference>
  <reference>
    <citation>Steffens JP, Wang X, Starr JR, Spolidorio LC, Van Dyke TE, Kantarci A. Associations Between Sex Hormone Levels and Periodontitis in Men: Results From NHANES III. J Periodontol. 2015 Oct;86(10):1116-25. doi: 10.1902/jop.2015.140530. Epub 2015 Jun 11.</citation>
    <PMID>26062840</PMID>
  </reference>
  <reference>
    <citation>Daltaban O, Saygun I, Bolu E. Periodontal status in men with hypergonadotropic hypogonadism: effects of testosterone deficiency. J Periodontol. 2006 Jul;77(7):1179-83.</citation>
    <PMID>16805680</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2017</study_first_submitted>
  <study_first_submitted_qc>June 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2017</study_first_posted>
  <last_update_submitted>June 1, 2017</last_update_submitted>
  <last_update_submitted_qc>June 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal do Paraná</investigator_affiliation>
    <investigator_full_name>Joao Paulo Steffens</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Hypogonadism</mesh_term>
    <mesh_term>Eunuchism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

